UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FGF19 promotes progression of prostate cancer

The Prostate, 2015-07, Vol.75 (10), p.1092-1101

2015

Volltextzugriff (PDF)

Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer

International urology and nephrology, 2020, Vol.52 (1), p.77-85

2020

Volltextzugriff (PDF)

Fibroblast Growth Factor Family in the Progression of Prostate Cancer

Journal of clinical medicine, 2019-02, Vol.8 (2), p.183

2019

Volltextzugriff (PDF)

The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

Anticancer research, 2020-08, Vol.40 (8), p.4787-4793

2020

Volltextzugriff (PDF)

Chromophobe renal cell carcinoma and ‘capsulomas’ with acquired cystic disease of the kidney in a long‐term hemodialysis patient

International journal of urology, 2008-06, Vol.15 (6), p.543-545

2008

Volltextzugriff (PDF)

Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer

Hiroshima journal of medical sciences, 2013-03, Vol.62 (1), p.13

2013

Volltextzugriff (PDF)

The impact of change in serum C‐reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma

BJU international, 2016-06, Vol.117 (6B), p.E67-E74

2016

Volltextzugriff (PDF)

MP41-20 FGF19 SUBFAMILY PROMOTES PROGRESSION IN PROSTATE CANCER CELLS

The Journal of urology, 2014-04, Vol.191 (4), p.e458-e458

2014

Volltextzugriff (PDF)

Accumulation of FGF9 in prostate cancer correlates with epithelial-to-mesenchymal transition and induction of VEGF-A expression

Anticancer research, 2014-02, Vol.34 (2), p.695-700

2014

Volltextzugriff (PDF)

MP92-09 COMBINATION THERAPY USING MOLECULAR-TARGETED DRUGS INHIBITING PLATELET-DERIVED GROWTH FACTOR RECEPTORS IN THE TUMOR MICROENVIRONMENT OF RENAL CELL CARCINOMA

The Journal of urology, 2016-04, Vol.195 (4), p.e1165-e1165

2016

Volltextzugriff (PDF)

MP66-16 REGENERATING ISLET-DERIVED RELATED PROTEIN 4 AS A CANDIDATE OF A NOVEL BIOMARKER IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS

The Journal of urology, 2016-04, Vol.195 (4), p.e878-e879

2016

Volltextzugriff (PDF)

496 FIBROBLAST GROWTH FACTOR 9 IN PROSTATE CANCER CELLS IS ASSOCIATED WITH POSTOPERATIVE RECURRENCE THROUGH ACCELERATION OF MESENCHYMAL TRANSITION, PROLIFERATION, AND INVASION

The Journal of urology, 2013-04, Vol.189 (4), p.e203-e204

2013

Volltextzugriff (PDF)

PD35-03 THE IMPACT OF CHANGE IN SERUM C-REACTIVE PROTEIN LEVEL ON THE PREDICTION OF EFFECTS OF MOLECULAR TARGETED THERAPY IN METASTATIC RENAL CELL CARCINOMA PATIENTS

The Journal of urology, 2015-04, Vol.193 (4), p.e760-e760

2015

Volltextzugriff (PDF)

Prostate cancer and metabolic syndrome

Nihon rinshō, 2016-01, Vol.74 (1), p.149

2016

Volltextzugriff (PDF)

MP49-09 REGENERATING ISLET-DERIVED FAMILY, MEMBER 4 ENHANCES CELL PROLIFERATION, CASTRATION-RESISTANCE, AND CHEMORESISTANCE THROUGH ACCELERATION OF NEUROENDOCRINE DIFFERENTIATION IN HUMAN PROSTATE CANCER CELLS

The Journal of urology, 2014-04, Vol.191 (4), p.e505-e505

2014

Volltextzugriff (PDF)

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

Oncology letters, 2014-08, Vol.8 (2), p.881-885

2014

Volltextzugriff (PDF)

1917 PROGNOSITIC SIGNIFICANCE OF C-REACTIVE PROTEIN IN INTERMEDIATE-RISK JAPANESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH MOLECULAR TARGETED THERAPY

The Journal of urology, 2013-04, Vol.189 (4), p.e786-e786

2013

Volltextzugriff (PDF)

LAPAROSCOPIC RADICAL PROSTATECTOMY OF 926 PATIENTS AT THE HIROSHIMA ENDOUROLOGICAL ASSOCIATION

Nippon Hinyokika Gakkai zasshi, 2019, Vol.110 (1), p.1-11

2019

Volltextzugriff (PDF)

Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels

Molecular and clinical oncology, 2017-05, Vol.6 (5), p.748-752

2017

Volltextzugriff (PDF)

LAPAROSCOPIC RADICAL PROSTATECTOMY OF 926 PATIENTS AT THE HIROSHIMA ENDOUROLOGICAL ASSOCIATION

The Japanese Journal of Urology, 2019/01/20, Vol.110(1), pp.1-11

2019

Volltextzugriff (PDF)

Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection

Canadian Urological Association journal, 2014-05, Vol.8 (5-6), p.E327-E332

2014

Volltextzugriff (PDF)

腹腔鏡下前立腺全摘除術926例の検証　―多施設共同研究

日本泌尿器科学会雑誌, 2019/01/20, Vol.110(1), pp.1-11

2019

Volltextzugriff (PDF)

Chromophobe renal cell carcinoma and 'capsulomas' with acquired cystic disease of the kidney in a long-term hemodialysis patient

International Journal of Urology, 2008, Vol.15 (6), p.543-545

2008

Volltextzugriff (PDF)

Correlation between antiphospholipid antibodies and the coagulation-fibrinolysis system in women with a history of miscarriage - comparison between conventional antiphospholipid antibodies and neo-self antibodies

Journal of reproductive immunology, 2022-09, Vol.153, p.103715, Article 103715

2022

Volltextzugriff (PDF)

High dynamic range and high dispersion stability of a magnetorheological grease damper for semi-active vibration suppression

Journal of intelligent material systems and structures, 2022-02, Vol.33 (3), p.419-431

2022

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(37)
Berichte
(1)

Sprache

Englisch
(34)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Humans
(10)
Male
(10)
Urology
(8)
Prostate Cancer
(7)
Animals
(5)
Oncology
(5)
Prostatectomy
(5)
Aged
(4)
Female
(4)
Health Aspects
(4)
Insulin
(4)
Insulin - Metabolism
(4)
Insulin-Secreting Cells - Metabolism
(4)
Mice
(4)
Middle Aged
(4)
Time Factors
(4)
Urology & Nephrology
(4)
Adult
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FGF19 promotes progression of prostate cancer

Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer

Fibroblast Growth Factor Family in the Progression of Prostate Cancer

The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

Chromophobe renal cell carcinoma and ‘capsulomas’ with acquired cystic disease of the kidney in a long‐term hemodialysis patient

Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer

The impact of change in serum C‐reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma

MP41-20 FGF19 SUBFAMILY PROMOTES PROGRESSION IN PROSTATE CANCER CELLS

Accumulation of FGF9 in prostate cancer correlates with epithelial-to-mesenchymal transition and induction of VEGF-A expression

MP92-09 COMBINATION THERAPY USING MOLECULAR-TARGETED DRUGS INHIBITING PLATELET-DERIVED GROWTH FACTOR RECEPTORS IN THE TUMOR MICROENVIRONMENT OF RENAL CELL CARCINOMA

MP66-16 REGENERATING ISLET-DERIVED RELATED PROTEIN 4 AS A CANDIDATE OF A NOVEL BIOMARKER IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS

496 FIBROBLAST GROWTH FACTOR 9 IN PROSTATE CANCER CELLS IS ASSOCIATED WITH POSTOPERATIVE RECURRENCE THROUGH ACCELERATION OF MESENCHYMAL TRANSITION, PROLIFERATION, AND INVASION

PD35-03 THE IMPACT OF CHANGE IN SERUM C-REACTIVE PROTEIN LEVEL ON THE PREDICTION OF EFFECTS OF MOLECULAR TARGETED THERAPY IN METASTATIC RENAL CELL CARCINOMA PATIENTS

Prostate cancer and metabolic syndrome

MP49-09 REGENERATING ISLET-DERIVED FAMILY, MEMBER 4 ENHANCES CELL PROLIFERATION, CASTRATION-RESISTANCE, AND CHEMORESISTANCE THROUGH ACCELERATION OF NEUROENDOCRINE DIFFERENTIATION IN HUMAN PROSTATE CANCER CELLS

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

1917 PROGNOSITIC SIGNIFICANCE OF C-REACTIVE PROTEIN IN INTERMEDIATE-RISK JAPANESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH MOLECULAR TARGETED THERAPY

LAPAROSCOPIC RADICAL PROSTATECTOMY OF 926 PATIENTS AT THE HIROSHIMA ENDOUROLOGICAL ASSOCIATION

Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels

LAPAROSCOPIC RADICAL PROSTATECTOMY OF 926 PATIENTS AT THE HIROSHIMA ENDOUROLOGICAL ASSOCIATION

Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection

腹腔鏡下前立腺全摘除術926例の検証　―多施設共同研究

Chromophobe renal cell carcinoma and 'capsulomas' with acquired cystic disease of the kidney in a long-term hemodialysis patient

Correlation between antiphospholipid antibodies and the coagulation-fibrinolysis system in women with a history of miscarriage - comparison between conventional antiphospholipid antibodies and neo-self antibodies

High dynamic range and high dispersion stability of a magnetorheological grease damper for semi-active vibration suppression

Suchergebnisse filtern